GRAVITAS-301 (#773)
Laufzeit: 01.01.2019 - 31.12.2021
Kurzfassung
A randomized, double-blind, placebo-controlled phase 3 study of Itacitinib or placebo in combination with corticosteroids for the treatment of first-line acute graft-versus-host disease
